Net Income at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's net income?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported net income of $22.59M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's net income changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's net income increased by 164.6% year-over-year, from $8.54M to $22.59M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's net income?
- Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's net income has grown at a -21.8% compound annual growth rate (CAGR), from -$157.92M to $59.01M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.